title: Mobilization of hematopoietic stem cells for use in autologous transplantation.
abstract: Autologous hematopoietic stem cell transplantation (HSCT) is a potentially curative therapeutic approach for various malignant hematologic and lymphoid diseases. Hematopoietic stem cells (HSCs) may be collected from the blood or the bone marrow. HSCs are capable of self-renewal and give rise to progenitor cells, multipotent cells that differentiate and proliferate into the mature cells of the blood and immune system. HSCs and progenitor cells are released from the bone marrow into the peripheral blood through a process called mobilization. HSCs then are collected from the blood in a process called apheresis and cryopreserved for administration following the high-dose preparative regimen. This article reviews stem cell biology, current mobilization strategies, use of novel mobilization agents, and nursing care of patients during the mobilization phase of autologous HSCT. Understanding the biology and process of HSC mobilization is critical for transplantation nurses to deliver and coordinate care during this complex phase of autologous HSCT.
authors.affiliation: James Cancer Hospital, Ohio State University Medical Center, Columbus, USA. hollie.devine@osumc.edu
authors.forename: Hollie
authors.initials: H
authors.lastname: Devine
authors.forename: D Kathryn
authors.initials: DK
authors.lastname: Tierney
authors.forename: Kim
authors.initials: K
authors.lastname: Schmit-Pokorny
authors.forename: Kathleen
authors.initials: K
authors.lastname: McDermott
mesh_terms: D001781:Blood Component Removal / Q000379:methods; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006412:Hematopoietic Stem Cells; D006801:Humans; D014182:Transplantation, Autologous